For melanoma, we found three eligible publications with 198 ICI-treated patients, and the observed hazard ratios for OS and PFS revealed a rather heterogeneous picture regarding the prognostic value of sPD-L1 in melanoma. This evidence concerns the gene SPDL1 and melanoma.